Ernexa Therapeutics Inc. Payments to Acquire Equipment on Lease
Ernexa Therapeutics Inc. (ERNA) reported Payments to Acquire Equipment on Lease of $160.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquipmentOnLease · last filed 2015-05-08
- Ernexa Therapeutics Inc. payments to acquire equipment on lease for the quarter ending 2015-03-31 was $160.00K.
- Ernexa Therapeutics Inc. payments to acquire equipment on lease for the quarter ending 2014-03-31 was $0.00.
- Ernexa Therapeutics Inc. payments to acquire equipment on lease for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- Ernexa Therapeutics Inc. payments to acquire equipment on lease for the quarter ending 2012-12-31 was $36.00K.
- Ernexa Therapeutics Inc. payments to acquire equipment on lease for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- Ernexa Therapeutics Inc. payments to acquire equipment on lease for fiscal 2013 was $23.00K, a 36.11% decline from fiscal 2012.
- Ernexa Therapeutics Inc. payments to acquire equipment on lease for fiscal 2012 was $36.00K.
| Period end | Payments to Acquire Equipment on Lease 3 month | Payments to Acquire Equipment on Lease 6 month | Payments to Acquire Equipment on Lease 9 month | Payments to Acquire Equipment on Lease 12 month |
|---|---|---|---|---|
| 2015-03-31 | $160.00K 10-Q · filed 2015-05-08 | |||
| 2014-12-31 | $0.00 10-K · filed 2015-03-27 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2015-05-08 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $23.00K 10-K · filed 2015-03-27 | ||
| 2013-09-30 | $23.00K 10-Q · filed 2013-11-14 | |||
| 2012-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $36.00K 10-K · filed 2014-03-31 | ||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |